Clinical Trial Update: Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of sunitinib in metastatic gastric cancer (gastric adenocarcinoma) has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Gastric Adenocarcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Gastric Adenocarcinoma, Barrett Esophagus | Phase 2 | Status: COMPLETED | Results posted: 2011-01-14